Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Quick facts

Phase 3 pipeline

• SSGJ-707 · Oncology
  SSGJ-707 is a small molecule that targets the PD-1/PD-L1 pathway.

Phase 2 pipeline

• 609A · Unknown
  609A is a small molecule drug that targets the molecular target.
• CPGJ602 · Diabetes
  CPGJ602 is a small molecule that targets the SGLT2 receptor.
• SSGJ-705

Phase 1 pipeline

• Drug 601
• existing formulations of 611
• new formulations of 611
• SSGJ-613

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. portfolio CI brief
• Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. pipeline updates RSS

Frequently asked questions about Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Related

• Sector hub: All tracked pharma companies